Evidence map›Paper›PMID 22384212›Full record

ArticlePloS one2012

Pivotal role of inosine triphosphate pyrophosphatase in maintaining genome stability and the prevention of apoptosis in human cells.

Miriam Rose Menezes, Irina S-R Waisertreiger, Hernando Lopez-Bertoni, Xu Luo, Youri I Pavlov

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Changes inFrontiers in plant science · 2023
    Article
  4. Review
  5. Review
  6. Article
  7. Comment on "A commensal strain ofScience advances · 2019
    Article
  8. Article
  9. Review
  10. A commensal strain ofScience advances · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Miriam Rose MenezesEppley Institute for Research in Cancer and Allied Diseases, Nebraska Medical Center, Omaha, Nebraska, United States of America.
Irina S-R Waisertreiger
Hernando Lopez-Bertoni
Xu Luo
Youri I Pavlov
Nebraska Medical Center · USUniversity of Nebraska Medical Center · US

Funding

Control of Genome Stability by Replicative DNA PolymerasesR01CA129925 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAVLOV, YOURI I · 2008 to 2012
$1.2M
NCI NIH HHS R01 CA129925
6 · The paper itself

Abstract

Pure nucleotide precursor pools are a prerequisite for high-fidelity DNA replication and the suppression of mutagenesis and carcinogenesis. ITPases are nucleoside triphosphate pyrophosphatases that clean the precursor pools of the non-canonical triphosphates of inosine and xanthine. The precise role of the human ITPase, encoded by the ITPA gene, is not clearly defined. ITPA is clinically important because a widespread polymorphism, 94C>A, leads to null ITPase activity in erythrocytes and is associated with an adverse reaction to thiopurine drugs. We studied the cellular function of ITPA in HeLa cells using the purine analog 6-N hydroxylaminopurine (HAP), whose triphosphate is also a substrate for ITPA. In this study, we demonstrate that ITPA knockdown sensitizes HeLa cells to HAP-induced DNA breaks and apoptosis. The HAP-induced DNA damage and cytotoxicity observed in ITPA knockdown cells are rescued by an overexpression of the yeast ITPase encoded by the HAM1 gene. We further show that ITPA knockdown results in elevated mutagenesis in response to HAP treatment. Our studies reveal the significance of ITPA in preventing base analog-induced apoptosis, DNA damage and mutagenesis in human cells. This implies that individuals with defective ITPase are predisposed to genome damage by impurities in nucleotide pools, which is drastically augmented by therapy with purine analogs. They are also at an elevated risk for degenerative diseases and cancer.

Indexed as

Apoptosisbcl-X ProteinComet AssayDNA DamageDNA ReplicationGenome, HumanHeLa CellsHumansHypoxanthineInosine TriphosphataseMutagenesisNeoplasmsNeurodegenerative DiseasesNucleotidesPolymorphism, GeneticPyrophosphatasesBCL2L1 protein, humanbcl-X ProteinHypoxanthineInosine TriphosphataseNucleotidesPyrophosphatases

Identifiers

PMID22384212
PMCPMC3288088
OpenAlexW1968616420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.